{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:30:29Z","timestamp":1791052229088,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.eururo.2006.02.018","type":"journal-article","created":{"date-parts":[[2006,2,20]],"date-time":"2006-02-20T15:57:23Z","timestamp":1140451043000},"page":"651-659","source":"Crossref","is-referenced-by-count":313,"title":["A Shifted Paradigm for the Further Understanding, Evaluation, and Treatment of Lower Urinary Tract Symptoms in Men: Focus on the Bladder"],"prefix":"10.1016","volume":"49","author":[{"given":"Christopher R.","family":"Chapple","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus G.","family":"Roehrborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2006.02.018_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1464-410X.2005.05406.x","article-title":"Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract","volume":"95","author":"Engstrom","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.02.018_bib2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0090-4295(03)00009-8","article-title":"Estimated economic costs of overactive bladder in the United States","volume":"61","author":"Hu","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.018_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","article-title":"Lower urinary tract symptoms and male sexual dysfunction: the Multinational Survey of the Aging Male (MSAM-7)","volume":"44","author":"Rosen","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.018_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-5347(01)65075-4","article-title":"The International Continence Society \u201cBenign Prostatic Hyperplasia\u201d Study: the bothersomeness of urinary symptoms","volume":"157","author":"Peters","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0090-4295(98)00048-X","article-title":"Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia","volume":"51","author":"Holtgrewe","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.018_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/bmj.308.6934.929","article-title":"New words for old: lower urinary tract symptoms for \u201cprostatism\u201d","volume":"308","author":"Abrams","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2006.02.018_bib8","unstructured":"Chatelain C, Denis L, Foo KT, Khoury S, McConnell J. Benign Prostatic Hyperplasia. 5th International Consultation on Benign Prostatic Hyperplasia; 2000; Paris, France."},{"key":"10.1016\/j.eururo.2006.02.018_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00005392-199907000-00035","article-title":"Urodynamic characterization of nonobstructive voiding dysfunction in symptomatic elderly men","volume":"162","author":"Ameda","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0090-4295(98)00532-9","article-title":"Benign prostatic hyperplasia: an overview","volume":"53","author":"Ziada","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.018_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/bmj.322.7278.106","article-title":"Benign prostatic hyperplasia has precise meaning","volume":"322","author":"Abrams","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2006.02.018_bib13","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1464-410X.2004.05158.x","article-title":"Serum prostate-specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms","volume":"94","author":"Laniado","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.02.018_bib14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0090-4295(01)01413-3","article-title":"Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia","volume":"58","author":"Eckhardt","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.018_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11934-002-0095-3","article-title":"Overactive bladder in the male patient: bladder, outlet, or both?","volume":"3","author":"Abdel-Aziz","year":"2002","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.eururo.2006.02.018_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.02.018_bib18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.eururo.2005.04.026","article-title":"Prevalence of the overactive bladder syndrome by applying the International Continence Society definition","volume":"48","author":"Temml","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1464-410X.1994.tb09182.x","article-title":"Urinary symptoms in the community: how bothersome are they?","volume":"74","author":"Jolleys","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4899-1585-6_2","article-title":"Bladder outlet obstruction\u2014an overview","volume":"385","author":"Wein","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.eururo.2006.02.018_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/nau.1001","article-title":"BPH with coexisting overactive bladder dysfunction\u2014an everyday urological dilemma","volume":"20","author":"Knutson","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.02.018_bib22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-5347(05)65862-4","article-title":"Videourodynamic studies in men with lower urinary tract symptoms: a comparison of community based versus referral urological practices","volume":"166","author":"Fusco","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.2004.05039.x","article-title":"Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder","volume":"94","author":"Lee","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.02.018_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0022-5347(05)65982-4","article-title":"Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings","volume":"166","author":"Hyman","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1464-410X.1987.tb04979.x","article-title":"The physiological response of the detrusor muscle to experimental bladder outflow obstruction in the pig","volume":"60","author":"Sibley","year":"1987","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib26","first-page":"S7","article-title":"Pathophysiology of overactive bladder and urge urinary incontinence","volume":"4","author":"Steers","year":"2002","journal-title":"Rev Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0090-4295(93)90332-5","article-title":"Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age","volume":"42","author":"Lepor","year":"1993","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.018_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.urology.2003.09.070","article-title":"Comparative analysis of lower urinary tract symptoms and bother in both sexes","volume":"63","author":"Terai","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.018_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/nau.1002","article-title":"Involuntary detrusor contractions: correlation of urodynamic data to clinical categories","volume":"20","author":"Romanzi","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.02.018_bib30","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/01.ju.0000049644.27713.c8","article-title":"Relationship of bladder dysfunction to lesion site in multiple sclerosis","volume":"169","author":"Araki","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0022-5347(17)35482-4","article-title":"Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia","volume":"150","author":"Barry","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/00365597909179530","article-title":"Prostatism. I. The correlation between symptoms, cystometric and urodynamic findings","volume":"13","author":"Andersen","year":"1979","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2006.02.018_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1520-6777(1998)17:2<99::AID-NAU3>3.0.CO;2-7","article-title":"Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-\u201cBPH\u201d study","volume":"17","author":"de la Rosette","year":"1998","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.02.018_bib34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/nau.10057","article-title":"Detrusor instability with equivocal obstruction: A predictor of unfavorable symptomatic outcomes after transurethral prostatectomy","volume":"21","author":"Machino","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.02.018_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0022-5347(17)56918-9","article-title":"The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients","volume":"121","author":"Abrams","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib36","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1517\/13543784.14.11.1359","article-title":"Benign prostatic hyperplasia: an insight into current investigational medical therapies","volume":"14","author":"Tiwari","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.eururo.2006.02.018_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00941983","article-title":"Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate","volume":"25","author":"Goepel","year":"1997","journal-title":"Urol Res"},{"key":"10.1016\/j.eururo.2006.02.018_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.ju.0000143198.16610.84","article-title":"Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin","volume":"173","author":"Bouchelouche","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.ju.0000067621.62736.7c","article-title":"A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders","volume":"170","author":"Nomiya","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0090-4295(96)00353-6","article-title":"Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials","volume":"48","author":"Boyle","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.018_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0149-2918(97)80113-0","article-title":"Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care study. Primary Care Investigator Study Group","volume":"19","author":"Tenover","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.eururo.2006.02.018_bib42","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0090-4295(02)01905-2","article-title":"Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia","volume":"60","author":"Roehrborn","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.018_bib43","unstructured":"Jumadilova Z, Harris H, del Aguila M, Wagner S, Boccuzzi S, Bavendam T. Agent selection for overactive bladder patients with and without documented comorbid benign prostatic hyperplasia (Read By Title). Presented at: International Continence Society; Aug 28\u2013Sept 2, 2005; Montreal, Canada."},{"key":"10.1016\/j.eururo.2006.02.018_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0090-4295(97)00591-8","article-title":"A myogenic basis for the overactive bladder","volume":"50","author":"Brading","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.018_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0090-4295(02)01788-0","article-title":"Pathophysiology: the varieties of bladder overactivity","volume":"60","author":"Mostwin","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.02.018_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00042307-200401000-00003","article-title":"Does anticholinergic medication have a role for men with lower urinary tract symptoms\/benign prostatic hyperplasia either alone or in combination with other agents?","volume":"14","author":"Reynard","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib47","unstructured":"Roehrborn CG, Guan Z, Wang JT, Rovner ES, Kaplan SA. Efficacy and safety of tolterodine in male patients with overactive bladder and urinary incontinence. Presented at: Society for Urodynamics and Female Urology; 2005; Orlando, FL."},{"key":"10.1016\/j.eururo.2006.02.018_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1569-9056(05)80243-X","article-title":"Gender analysis of data from two 12-week randomized controlled trials of tolterodine: tolterodine reduces overactive bladder-related nocturnal frequency in men and women with overactive bladder","volume":"4","author":"Marschall-Kehrel","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib49","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/01.ju.0000181823.33224.a0","article-title":"Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"174","author":"Kaplan","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2005.02.024","article-title":"The effects of antimuscarinic treatments in overactive bladder: A systematic review and meta-analysis","volume":"48","author":"Chapple","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib51","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0022-5347(05)00483-0","article-title":"Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction","volume":"175","author":"Abrams","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib52","first-page":"267","article-title":"Nomogram and urodynamic predictors of urinary retention in men with BPH and bladder outlet obstruction","volume":"165 (Suppl)","author":"Te","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s003450050079","article-title":"Mechanisms of bladder smooth-muscle hypertrophy and decompensation: lessons from normal development and the response to outlet obstruction","volume":"16","author":"Zderic","year":"1998","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib54","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0022-5347(01)66073-7","article-title":"Detrusor contractility and compliance characteristics in adult male patients with obstructive and nonobstructive voiding dysfunction","volume":"155","author":"Sullivan","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib55","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/01.ju.0000067541.73285.eb","article-title":"Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study","volume":"169","author":"Athanasopoulos","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2004.10.015","article-title":"Overactive bladder: a clinical entity or a marketing hype?","volume":"47","author":"Madersbacher","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurol Urodyn"},{"key":"10.1016\/j.eururo.2006.02.018_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00042307-200401000-00003","article-title":"Does anticholinergic medication have a role for men with lower urinary tract symptoms\/benign prostatic hyperplasia either alone or in combination with other agents?","volume":"14","author":"Reynard","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2006.02.018_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1474-4422(03)00622-7","article-title":"Antimuscarinics for treatment of overactive bladder","volume":"3","author":"Andersson","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eururo.2006.02.018_bib60","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.2004.05039.x","article-title":"Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder","volume":"94","author":"Lee","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.02.018_bib61","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/01.ju.0000067541.73285.eb","article-title":"Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomised, controlled study","volume":"169","author":"Athanasopoulos","year":"2003","journal-title":"J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806001898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806001898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T20:38:16Z","timestamp":1586723896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283806001898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0302283806001898"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2006.02.018","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}